Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer immunotherapy using checkpoint blockade
Antoni Ribas, Jedd D. Wolchok
Science (2018) Vol. 359, Iss. 6382, pp. 1350-1355
Open Access | Times Cited: 5337

Showing 1-25 of 5337 citing articles:

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei, Colm R. Duffy, James P. Allison
Cancer Discovery (2018) Vol. 8, Iss. 9, pp. 1069-1086
Open Access | Times Cited: 2588
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
Yijing Liu, Pravin Bhattarai, Zhifei Dai, et al.
Chemical Society Reviews (2018) Vol. 48, Iss. 7, pp. 2053-2108
Open Access | Times Cited: 2456
Delivery technologies for cancer immunotherapy
Rachel Riley, Carl H. June, Róbert Langer, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 175-196
Open Access | Times Cited: 2129
A view on drug resistance in cancer
Neil Vasan, José Baselga, David M. Hyman
Nature (2019) Vol. 575, Iss. 7782, pp. 299-309
Open Access | Times Cited: 2046
TISIDB: an integrated repository portal for tumor–immune system interactions
Beibei Ru, Ching Ngar Wong, Yin Tong, et al.
Bioinformatics (2019) Vol. 35, Iss. 20, pp. 4200-4202
Closed Access | Times Cited: 1842
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
Sreya Bagchi, Robert Yuan, Edgar G. Engleman
Annual Review of Pathology Mechanisms of Disease (2020) Vol. 16, Iss. 1, pp. 223-249
Open Access | Times Cited: 1579
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
Laura M. McLane, Mohamed S. Abdel-Hakeem, E. John Wherry
Annual Review of Immunology (2019) Vol. 37, Iss. 1, pp. 457-495
Open Access | Times Cited: 1491
Tertiary lymphoid structures in the era of cancer immunotherapy
Catherine Sautès‐Fridman, Florent Petitprez, Julien Caldéraro, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 6, pp. 307-325
Open Access | Times Cited: 1303
Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
Imran Siddiqui, Karin Schaeuble, Vijaykumar Chennupati, et al.
Immunity (2019) Vol. 50, Iss. 1, pp. 195-211.e10
Open Access | Times Cited: 1245
Tumor microenvironment as a therapeutic target in cancer
Yi Xiao, Dihua Yu
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107753-107753
Open Access | Times Cited: 1226
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed, Lieping Chen
Cell (2018) Vol. 175, Iss. 2, pp. 313-326
Open Access | Times Cited: 1192
Immunotherapies for hepatocellular carcinoma
Josep M. Llovet, Florian Castet, Mathias Heikenwälder, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 3, pp. 151-172
Closed Access | Times Cited: 1164
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
Lei Zhang, Ziyi Li, Katarzyna M. Skrzypczynska, et al.
Cell (2020) Vol. 181, Iss. 2, pp. 442-459.e29
Open Access | Times Cited: 1109
Smart cancer nanomedicine
Roy van der Meel, Einar Sulheim, Yang Shi, et al.
Nature Nanotechnology (2019) Vol. 14, Iss. 11, pp. 1007-1017
Open Access | Times Cited: 1026
Immune checkpoint signaling and cancer immunotherapy
Xing He, Chenqi Xu
Cell Research (2020) Vol. 30, Iss. 8, pp. 660-669
Open Access | Times Cited: 977
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Élie Salem, Ali Manouchehri, Melissa Moey, et al.
The Lancet Oncology (2018) Vol. 19, Iss. 12, pp. 1579-1589
Open Access | Times Cited: 970
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
Hanjie Li, Anne M. van der Leun, Ido Yofe, et al.
Cell (2018) Vol. 176, Iss. 4, pp. 775-789.e18
Open Access | Times Cited: 943
Advances in immunotherapy for hepatocellular carcinoma
Bruno Sangro, Pablo Sarobe, Sandra Hervás‐Stubbs, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 8, pp. 525-543
Open Access | Times Cited: 938
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Leeat Keren, Marc Bossé, Diana M. Marquez, et al.
Cell (2018) Vol. 174, Iss. 6, pp. 1373-1387.e19
Open Access | Times Cited: 902
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Xiaopin Duan, Christina Chan, Wenbin Lin
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 3, pp. 670-680
Open Access | Times Cited: 858
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen, Chao Wang, Xudong Zhang, et al.
Nature Nanotechnology (2018) Vol. 14, Iss. 1, pp. 89-97
Closed Access | Times Cited: 853
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000337-e000337
Open Access | Times Cited: 849
A bioorthogonal system reveals antitumour immune function of pyroptosis
Qinyang Wang, Yupeng Wang, Jingjin Ding, et al.
Nature (2020) Vol. 579, Iss. 7799, pp. 421-426
Closed Access | Times Cited: 810
Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion
Ansuman T. Satpathy, Jeffrey M. Granja, Kathryn E. Yost, et al.
Nature Biotechnology (2019) Vol. 37, Iss. 8, pp. 925-936
Open Access | Times Cited: 804
Targeting Tumor-Associated Macrophages in Cancer
Paulina Pathria, Tiani L. Louis, Judith A. Varner
Trends in Immunology (2019) Vol. 40, Iss. 4, pp. 310-327
Closed Access | Times Cited: 798
Page 1 - Next Page

Scroll to top